Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

Vaccine side effects very rare, says DDC

Few side effects have been reported among the 120 million Covid-19 vaccine doses administered, according to the Department of Disease Control (DDC).

Bangkok Post

Covid: South Korea reports more than 100,000 new cases for first time – as it happened

Latest updates: south Korean case numbers have risen in recent weeks due to Omicron

The Guardian - UK

Opinion: China Has Approved Pfizer’s Covid Drug. What’s Next?

The government now needs to place an order and set a delivery schedule, given the limited supply

Caixin Global

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA says official suggesting annual COVID vaccines ‘does not work on vaccine matters’

A video has emerged of a Food and Drug Administration executive suggesting there are plans for annual COVID-19 vaccines to be implemented in the United States.

McClatchy Washington Bureau

Pfizer/BioNTech's Omicron-Targeted COVID-19 To Miss March Timeline: Reuters

Pfizer Inc (NYSE: PFE) / BioNTech SE's (NASDAQ: BNTX) omicron-targeted COVID-19 vaccine is delayed by several weeks due to a slower-than-expected data gathering process,

Benzinga

Can my child have the Covid vaccine – and what are the side effects?

The Covid vaccine programme has been extended further to include children aged five to 11 without underlying health conditions, in a bid to protect against potential future waves of Covid-19

Daily Mirror

This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart

Macy's Inc (NYSE: M) retail stores have something for everyone in the family, and over the past year, has returned unmistakable gains for bullish traders and investors.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

‘Game changer’ Pfizer pill is easier to find as omicron fades away

As the omicron wave peaked in the U.S. last month, the first-line treatment for high-risk patients with early COVID-19 dangled out of reach for most. Only a trickle of the new Paxlovid pill from Pfizer Inc. was reaching hospitals and pharmacies.

Tribune News Service

This Is What Whales Are Betting On Pfizer

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 25 strange trades.

Benzinga

Five- to 11-year-old children in England to be offered Covid vaccine

Pfizer/BioNTech jab to be offered to younger children as experts decide benefits outweigh risks

The Guardian - UK

Germany and Switzerland set to ease restrictions – as it happened

This blog is now closed.

The Guardian - UK

Vaccinated people less likely to get long Covid than unvaccinated, new study shows

Review finds those who have received two doses of Pfizer/BioNTech, AstraZeneca or Moderna vaccine, or one dose of single-shot J&J vaccine, half as likely to develop long Covid symptoms

The Independent UK

COVID: China is developing its own mRNA vaccine – and it's showing early promise

China, the country that first detected the novel coronavirus, remains one of the few not to have imported one of the exceptionally effective mRNA COVID vaccines developed by Pfizer and Moderna. Instead, it has so far relied on vaccines developed by two Chinese companies, Sinovac and Sinopharm. However, this may…

The Conversation

Most parents back jabs for kids

Most parents want their children aged 5-11 to be vaccinated and prefer they receive the Pfizer vaccine produced using mRNA technology, a survey has revealed.

Bangkok Post

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Pfizer Shares Are Trading Lower Today

Pfizer Inc (NYSE: PFE) is trading lower Monday after the U.S. Food and Drug Administration (FDA) requested additional data before approving its COVID-19 vaccine for children aged six months to four years old.

Tribune News Service

China’s approval of Pfizer pill opens door to ending COVID Zero

China’s surprise decision to clear Pfizer Inc.’s coronavirus pill for use offers rare insight into how Beijing may be planning to move beyond the COVID Zero strategy that’s leaving it increasingly isolated.

The Guardian - AU

Coronavirus live: UK records 41,648 new cases and 35 Covid-linked deaths; French protest convoy reaches Brussels – as it happened

UK cases down 30% on the previous week, with weekly deaths down 27.2%; 500 French vehicles arrive in Brussels to protest against Covid measures

Tribune News Service

More than 600 in Connecticut must be revaccinated due to improper storage of Pfizer shot

More than 600 people recently vaccinated against COVID-19 in Connecticut must get the jab again because of improper storage of the shots.

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Hundreds vaccinated in Conn. will need another shot due to improper storage, officials say

HARTFORD, Conn. — Nearly 650 people who received a Pfizer COVID-19 vaccine at a clinic in New Haven between Christmas and Feb. 7 will need to get another shot, city health officials said late Friday, because the vaccine was improperly stored.

Axios

Experts praise Pfizer's delay on kids' vaccines

Experts say waiting for data on three doses is the right call.

Salon

Covid vaccine for young kids delayed

The FDA says it needs more time to review data on a potential three-dose vaccine for children aged 6 months to four

Asharq Al-Awsat

Covid Booster Efficacy Wanes Significantly by Fourth Month

The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday. Though it's now well documented that vaccine efficacy goes down after two doses, relatively little…

Asharq Al-Awsat

China Gives Conditional Approval for Pfizer Covid Pill

China on Saturday said it had given "conditional" approval for Pfizer's Covid-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease. The drug has so far been authorized in about 40 countries including the United States and Israel, while the European…

Bangkok Post

China approves Pfizer Covid pill

China has granted emergency approval for a Pfizer Covid-19 pill in a promising sign that the country could open up further to foreign vaccines and treatments for the virus.

Tribune News Service

China grants approval for Pfizer’s antiviral COVID pill

China granted emergency approval for Pfizer’s COVID-19 pill in a promising sign the country could open up further to foreign vaccines and treatments for the virus.

1 … 65 66 67 68

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

2,619 stories

Pfizer

1,788 stories

World Health Organization

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.